Autolus Therapeutics (AUTL) Misses Q3 EPS by 10c
Tweet
Share
E-mail
Get Alerts AUTL Hot Sheet
Join SI Premium – FREE
Autolus Therapeutics (NASDAQ: AUTL) reported Q3 EPS of ($0.31), $0.10 worse than the analyst estimate of ($0.21).
For earnings history and earnings-related data on Autolus Therapeutics (AUTL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HighPeak Energy mulls sale - Reuters
- U.S. approves visas for top Iranian leaders to attend UN high-level meeting - AP
- SpaceX: targeting to launch Starship flight 14 early as Sep 28
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
